Monitor for any follow-up filings or commentary around executive sentiment; current activity is within normal ranges and not materially bearish given the company's size.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Mar 4 $79.47entry
- T+1 · 9mo ago +3.18%α +3.76% · $82.00
- T+5 · 8mo ago +7.08%α +8.42% · $85.10
- T+20 · 8mo ago −17.55%α −13.14% · $65.52
- T+60 · 6mo ago −36.89%α −46.98% · $50.15
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
GeneDx CEO and CFO conducted open-market share sales totaling $587,754 over four days, while also receiving non-cash stock awards and exercising options. The sales represent a routine level of insider activity relative to the company's $2.3B market cap.
Key Financial Metrics
Key Facts
- CEO Katherine Stueland sold 5,861 shares for $454,967 in an open-market transaction.
- CFO Kevin Feeley sold a total of 1,711 shares across two transactions for $132,787.
- Total open-market sales by insiders in the cluster amount to $587,754 over seven days.
- CEO and CFO also received stock awards totaling 62,946 shares with no cash value (non-cash events).
- CFO exercised 718 shares via derivative, a non-cash transaction.
Financial Impact
$587,754 in net open-market selling by C-suite executives
Risk Factors
- Perception risk from concentrated C-suite selling, despite being routine in magnitude.
- Potential misinterpretation of non-cash awards as insider buying, these are standard compensation grants.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (6 trades, 7d window) | cluster-WGS-1772751291167 |
Track record
13 reports on WGS
5 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +63.51% at T+60 after the May 20, 2026 report. 7 of 7 went positive at some point.
Filters
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $52.37 Now $51.02 −2.58% settles Feb 11
- Nov 9, 20267d ago 8-K Bullish 6/10 Entry $54.83 Now $51.02 −6.95% settles Feb 8
- Nov 6, 202610d ago SC 13G Neutral 3/10 Entry $62.37 Now $51.02 −18.20% settles Feb 4
- Sep 18, 20268w ago Insider Cluster Bearish 4/10 Entry $97.83 Now $51.02 +47.85% settles Dec 15
- Sep 11, 20269w ago Insider Cluster Neutral 2/10 Entry $89.74 Now $51.02 −43.15% settles Dec 8
- Sep 1, 202610w ago 144 Neutral 2/10 Entry $86.72 Now $51.02 −41.17% settles Nov 27
- Jun 16, 202621w ago 8-K Neutral 3/10 Entry $60.60 to $83.96 Now $51.02 −15.81% ▲ +38.55% +37.55% vs SPY
- Jun 11, 202622w ago Institutional Cluster Bullish 4/10 Entry $59.92 to $85.87 Now $51.02 −14.85% ▲ +43.31% +40.04% vs SPY
- Jun 8, 202623w ago Insider Cluster Bullish 6/10 Entry $56.33 to $86.72 Now $51.02 −9.43% ▲ +53.95% +50.14% vs SPY
- May 20, 202625w ago Insider Cluster Bullish 6/10 Entry $47.33 to $77.39 Now $51.02 +7.80% ▲ +63.51% +59.21% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers